An update on COVID-19 infection control measures, plasma-based therapeutics, corticosteroid pharmacotherapy and vaccine research-Reference-Cited by-同舟云学术

An update on COVID-19 infection control measures, plasma-based therapeutics, corticosteroid pharmacotherapy and vaccine research

Published:2020-10 Issue:5 Volume:59 Page:102934
ISSN:1473-0502
Container-title:Transfusion and Apheresis Science
language:en
Short-container-title:Transfusion and Apheresis Science

Author:

Putter Jeffrey S.,Seghatchian Jerard

Publisher

Elsevier BV

Subject

Hematology

Reference11 articles.

1. Treatment for emerging viruses: convalescent plasma and COVID-19;Brown;Transfus Apher Sci,2020

2. Convalescent Plasma, an Apheresis research Project by targeting and motivating the Fully Recovered COVID-19 patients: a rousing message of clinical benefits to both donors/ recipients alike;Seghatchian;Transfus Apher Sci,2020

3. Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease for transfusion as an empirical treatment during outbreaks 2014;WHO,2020

4. Ebola virus convalescent blood products: where we are now and where we may need to go;Burnouf;Transfus Apher Sci,2020

5. Spotlight: COVID-19, induced activation of haemostais, and immune reactions: can an auto-immune reaction contribute to the delayed severe complications observed in some patients;Amiral;Transfus Apher Sci,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spotlights on the latest opinions on identification, prevention, and management of newer CoV-2 variants: A roundup appraisal on innovative ideas and designer vaccines for Omicron;Transfusion and Apheresis Science;2022-12

2. Passive Immunotherapeutic Approaches for Treating Covid-19: A Comprehensive Review;International Journal Of Pharmaceutical Research And Allied Sciences;2022

3. Alamandine: Potential Protective Effects in SARS-CoV-2 Patients;Journal of the Renin-Angiotensin-Aldosterone System;2021-11-08

4. Immunotherapy for COVID-19: Evolving treatment of viral infection and associated adverse immunological reactions;Transfusion and Apheresis Science;2021-04

5. COVID-19 and Hyperimmune sera: A feasible plan B to fight against coronavirus;International Immunopharmacology;2021-01